-
1. Continuous glucose monitoring metrics following sub-Tenon's injection of triamcinolone acetonide for diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 262:449-456,2024.
Sotani-Ogawa R, Kusuhara S, Hirota Y, Kim KW, Matsumiya W, Ogawa W, Nakamura M
-
2. Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology. Graefes Arch Clin Exp Ophthalmol,2024.
Nakao S, Kusuhara S, Murakami T
-
3. Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema. Medicina （Kaunas） 59,2023.
Kusuhara S, Kishimoto-Kishi M, Matsumiya W, Miki A, Imai H, Nakamura M
-
4. The heyday of optical coherence tomography angiography is just around the corner. Graefes Arch Clin Exp Ophthalmol 261:337-338,2023.
Kusuhara S
-
5. Outcomes of Microhook ab Interno Trabeculotomy in Consecutive 36 Eyes with Uveitic Glaucoma. J Clin Med 11,2022.
Sotani N, Kusuhara S, Matsumiya W, Okuda M, Mori S, Sotani R, Kim KW, Nishisho R, Nakamura M
-
6. Treatment of diabetic macular edema in real-world clinical practice: The effect of aging. J Diabetes Investig 13:1339-1346,2022.
Kusuhara S, Shimura M, Kitano S, Sugimoto M, Muramatsu D, Fukushima H, Takamura Y, Matsumoto M, Kokado M, Kogo J, Sasaki M, Morizane Y, Utsumi T, Kotake O, Koto T, Terasaki H, Hirano T, Ishikawa H, Mitamura Y, Okamoto F, Kinoshita T, Kimura K, Yamashiro K, Suzuki Y, Hikichi T, Washio N, Sato T, Ohkoshi K, Tsujinaka H, Kondo M, Takagi H, Murata T, Sakamoto T, Japan Clinical Retina Study g
-
7. Angiographic findings before and after the onset of brolucizumab-associated retinal vascular occlusion and intraocular inflammation. Am J Ophthalmol Case Rep 26:101521,2022.
Kusuhara S, Kim KW, Miki A, Nakamura M
-
8. Changes in choroidal imaging parameters following adalimumab therapy for refractory noninfectious uveitis. Graefes Arch Clin Exp Ophthalmol 259:1273-1280,2021.
Nishisho R, Kusuhara S, Sotani N, Kim KW, Katsuyama-Yoshikawa A, Matsumiya W, Akashi K, Morinobu A, Nakamura M
-
9. Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy. PLoS One 16:e0248760,2021.
Miki A, Kusuhara S, Otsuji T, Kawashima Y, Miki K, Imai H, Nakamura M, Tsujikawa A
-
10. Changes in Gene Expression Profiling and Phenotype in Aged Multidrug Resistance Protein 4-Deficient Mouse Retinas. Antioxidants （Basel） 10,2021.
Kim KW, Kusuhara S, Katsuyama-Yoshikawa A, Nobuyoshi S, Kitamura M, Mori S, Sotani N, Ueda K, Matsumiya W, Miki A, Kurimoto T, Imai H, Nakamura M
-
11. Outcomes of Primary 27-Gauge Vitrectomy for 73 Consecutive Cases With Uveitis-Associated Vitreoretinal Disorders. Front Med （Lausanne） 8:755816,2021.
Kim KW, Kusuhara S, Imai H, Sotani N, Nishisho R, Matsumiya W, Nakamura M
-
12. Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma: Safety, Efficacy, and Patient Selection. Clin Ophthalmol 14:1229-1236,2020.
Kusuhara S, Nakamura M
-
13. En face slab optical coherence tomography imaging successfully monitors progressive degenerative changes in the innermost layer of the diabetic retina. BMJ Open Diabetes Res Care 8,2020.
Katsuyama A, Kusuhara S, Asahara SI, Nakai SI, Mori S, Matsumiya W, Miki A, Kurimoto T, Imai H, Kido Y, Ogawa W, Nakamura M
-
14. Impaired Retinal Circulation during Axitinib Treatment for Metastatic Renal Cell Carcinoma. Case Rep Ophthalmol 10:5-10,2019.
Kimura M, Kusuhara S, Tagami M, Nakamura M
-
15. Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behcet's disease. Clin Ophthalmol 13:521-527,2019.
Katsuyama A, Kusuhara S, Nishisho R, Matsumiya W, Azumi A, Nakamura M
-
16. Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol 256:809-814,2018.
Kusuhara S, Katsuyama A, Matsumiya W, Nakamura M
-
17. Pathophysiology of Diabetic Retinopathy: The Old and the New. Diabetes Metab J 42:364-376,2018.
Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A
-
18. Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown. JCI Insight 2:e90905,2017.
Ogura S, Kurata K, Hattori Y, Takase H, Ishiguro-Oonuma T, Hwang Y, Ahn S, Park I, Ikeda W, Kusuhara S, Fukushima Y, Nara H, Sakai H, Fujiwara T, Matsushita J, Ema M, Hirashima M, Minami T, Shibuya M, Takakura N, Kim P, Miyata T, Ogura Y, Uemura A
-
19. Identification of myopia-associated WNT7B polymorphisms provides insights into the mechanism underlying the development of myopia. Nat Commun 6:6689,2015.
Miyake M, Yamashiro K, Tabara Y, Suda K, Morooka S, Nakanishi H, Khor CC, Chen P, Qiao F, Nakata I, Akagi-Kurashige Y, Gotoh N, Tsujikawa A, Meguro A, Kusuhara S, Polasek O, Hayward C, Wright AF, Campbell H, Richardson AJ, Schache M, Takeuchi M, Mackey DA, Hewitt AW, Cuellar G, Shi Y, Huang L, Yang Z, Leung KH, Kao PYP, Yap MKH, Yip SP, Moriyama M, Ohno-Matsui K, Mizuki N, MacGregor S, Vitart V, Aung T, Saw SM, Tai ES, Wong TY, Cheng CY, Baird PN, Yamada R, Matsuda F, Nagahama Study G, Yoshimura N
-
20. Predicting visual outcome following surgery for idiopathic macular holes. Ophthalmologica 231:125-132,2014.
Kusuhara S, Negi A
-
21. Evaluating dissociated optic nerve fiber layer appearance using en face layer imaging produced by optical coherence tomography. Ophthalmologica 232:170-178,2014.
Kusuhara S, Matsumiya W, Imai H, Honda S, Tsukahara Y, Negi A
-
22. Forskolin modifies retinal vascular development in Mrp4-knockout mice. Invest Ophthalmol Vis Sci 53:8029-8035,2012.
Matsumiya W, Kusuhara S, Hayashibe K, Maruyama K, Kusuhara H, Tagami M, Schuetz JD, Negi A
-
23. Arhgef15 promotes retinal angiogenesis by mediating VEGF-induced Cdc42 activation and potentiating RhoJ inactivation in endothelial cells. PLoS One 7:e45858,2012.
Kusuhara S, Fukushima Y, Fukuhara S, Jakt LM, Okada M, Shimizu Y, Hata M, Nishida K, Negi A, Hirashima M, Mochizuki N, Nishikawa S, Uemura A
-
24. Intraocular gas dynamics after 20-gauge and 23-gauge vitrectomy with sulfur hexafluoride gas tamponade. Retina 31:250-256,2011.
Kusuhara S, Ooto S, Kimura D, Itoi K, Mukuno H, Miyamoto N, Akimoto M, Takagi H
-
25. Outcomes of 23- and 25-gauge transconjunctival sutureless vitrectomies for idiopathic macular holes. Br J Ophthalmol 92:1261-1264,2008.
Kusuhara S, Ooto S, Kimura D, Itoi K, Mukuno H, Miyamoto N, Akimoto M, Kuriyama S, Takagi H
-
26. Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes. J Clin Invest 116:369-377,2006.
Uemura A, Kusuhara S, Wiegand SJ, Yu RT, Nishikawa S
-
27. Prediction of postoperative visual outcome based on hole configuration by optical coherence tomography in eyes with idiopathic macular holes. Am J Ophthalmol 138:709-716,2004.
Kusuhara S, Teraoka Escano MF, Fujii S, Nakanishi Y, Tamura Y, Nagai A, Yamamoto H, Tsukahara Y, Negi A
